Introduction
Human papillomavirus (HPV) is currently considered as the main aetiological factor of cervical cancer and its precursor cervical intraepithelial neoplasia (CIN). 1 The integration of HPV DNA in the human genome is crucial for persistence of the virus and its carcinogenic eVects. Molecular mechanisms and cellular events associated with viral persistence are still poorly understood, although it seems likely that a permissive viral replication increases the viral load in infected cells. Correlation between the viral load and persistence of the infection is indirect; in women with HPV induced cytopathic changes, a high load of oncogenic HPV types is strongly associated with CIN 2 and CIN 3. 2 The role of smoking as a risk factor for CIN and cervical cancer has been repeatedly emphasised starting from the late 1980s, although the results still remain controversial. [3] [4] [5] [6] [7] [8] This study was designed to evaluate the independent role of current smoking and viral load of the oncogenic (high risk) HPV types as predisposing factors for CIN 2 and CIN 3.
Material and methods
The subjects of this study were selected among 163 women referred to the colposcopy clinics of Leonor Mendes de Barros and CAISM/ UNICAMP hospitals, between September 1995 and August 1997 because of HPV suggestive abnormalities in their Papanicolaou smears. The protocol was approved by the institutional review board, and all women gave informed consent. The patients filled in a detailed questionnaire requesting their social, sexual, and reproductive histories.
A total of 148 women aged between 18 and 36 years (mean 27 years), who presented with an abnormal pattern on colposcopy warranting a directed punch biopsy, were included. Histological changes were evaluated according to the WHO classification 9 into the following categories: absence of HPV lesion, CIN 1, CIN 2, or CIN 3. On light microscopy, 42 women showed no HPV lesion on the cervix, 69 had CIN 1, 24 showed a CIN 2, and 13 showed CIN 3.
For the HPV DNA analysis, the first generation hybrid capture (HC) HPV DNA assay, including high risk HPV probes for types 16, 18, 31, 33, 35, 45, 51, 52, and 56 was used according to the instructions of the manufacturer (Digene, USA). A cut oV level of 1 relative light unit (RLU) was used, signifying that the samples with light emission higher than 1 RLU are considered HPV positive. Based in the data of Wright et al 10 the viral load was classified as low when ranging from 1 to 5 RLU, intermediate when ranging from 5.1 to 20 RLU, and high when above 20 RLU. HC, colposcopy, and directed biopsy were collected with a median interval of 13 weeks (minimal of 4 and maximal 21 weeks) after the Pap smears.
The distribution of the risk factors was compared among women with no HPV lesion and CIN by univariate logistic regression, and the odds ratio was calculated with a confidence interval of 95%. After this, a polytomous logistic regression analysis model was used to check the independent associations between the studied variables and CIN. Because CIN 2 and 3 are considered high grade lesions they were analysed together. By choosing the women with no HPV lesions as the base category for the dependent variable, the model estimated two risk equations simultaneously: (a) the odds for having CIN 1 v no HPV lesion and (b) the odds for having CIN 2 and 3 v no HPV lesion. In all data analysis, EPI-INFO 6.02 and SAS (Statistical Analysis System) were used.
Results
The overall detection rate of HPV DNA was 48% (71/148 women) and the detection rate increased significantly with the grade of CIN. The probability of CIN 2 and CIN 3 was also directly related to the viral load. Accordingly, odds ratio (OR) for CIN 2 or 3 was 14.57 in women with low viral load, reaching the value of 20.64 in those with a high viral load, compared with the women with a negative HC test (table 1) .
An early onset of sexual activity, cigarette smoking, and the presence of HPV DNA were factors associated with CIN 2 or 3 in the polytomous logistic regression analysis (table 2) . Women who smoke presented with an adjusted OR of 4.37 for having developed CIN 2 or 3 compared with the non-smokers. Women with positive HC test for the oncogenic HPV DNA had an adjusted OR 14.40 of presenting CIN 2 or 3 compared with those who tested as HPV negative.
Discussion
Among the 148 young Brazilian women analysed in the present study, the association of current smoking with the severity of CIN was evident and remained as an independent risk factor, significantly associated with CIN 2 and 3 in the multivariate analysis as well. The results are in alignment with other recent studies. Thus, Olsen et al established an intimate interrelation between smoking, high risk HPV type 16, and CIN 2/3: the OR for CIN 2 and 3 in HPV type 16 positive smokers and nonsmokers was 65.9 and 15.7, respectively. 8 The same was true with the detection of high risk HPV DNA in these women, which is in alignment with the data of Kanetsky et al who also demonstrated an association between cigarette smoking and cervical dysplasia in nonHispanic black women, after adjustment for HPV infection (HC assay). 6 Recently, the viral load has been associated with CIN in cross sectional studies. In our series, the adjusted OR of presenting with CIN 2 or CIN 3 was 14.40 times higher in women with positive HC test (for oncogenic types), and the viral load was directly related to the grade of CIN. However, to more accurately predict the prognostic value of the viral load, it would be important to specifically assess the role of individual HPV types, and not merely examine the load of the virus pool included in the HC test.
Of the other risk factors established in the present series, the onset of sexual activity before the age of 18 contracted an adjusted OR of 3.22 for CIN 2/3. An early age at the first intercourse predisposes the woman to any sexually transmitted agents (such as HPV). The same eVect is exerted by the number of lifetime sexual partners, established as a risk factor for CIN 2/3 in a number of epidemiological studies. 9 11 Although subjected to the potential temporal biases of a cross sectional study, the present series clearly demonstrates that the severity of the cervical precancer lesions is closely associated with (1) the presence of oncogenic HPV DNA, (2) cigarette smoking, and (3) early onset of sexual activity. The increase of the viral load was directly related to CIN 2/3. Taken together with the current data on the causal role of HPV in cervical carcinogenesis, the present results imply that smoking and HPV might act synergistically in this process. [3] [4] [5] [6] [7] [8] To further elucidate the mechanisms of these suspected synergistic actions between HPV and cigarette smoke, however, additional experimental studies are necessary.
This study has been supported by a research grant from the research support fund of the state of São Paulo, FAPESP (grant number 96/1730-5).
Contributors: SFM Derchain had the initial idea for this project focused on analysing the interrelations of smoking and HPV in the development of CIN; CM Roteli-Martins, examined all patients and collected the data. Together, these two authors also wrote the project plan and the first version of this manuscript. KJ Syrjänen has given constructive advice concerning the project design, as well as the composition of the manuscript, including the discussion of the results in proper context, statistical tests, and revising the English language of the paper as well as making suggestions to pertinent references. HJ de Abreu and EZ Martinez participated in the design of the study and they also made the statistical analysis. VAF Alves suggested the use of hybrid capture, and also read and classified all the cervical biopsies. The likelihood ratio statistic has a value of 11.70 with eight degrees of freedom, which is indicative of a good fit (p=0.17), adjusted by race, schooling, lifetime number of sexual partners, and parity.
